Continuous Venovenous Hemodiafiltration Versus Sustained Low-efficiency Hemodialysis for Critically Ill Patients With Acute Kidney Injury in Intensive Care Unit
Launched by BANGKOK METROPOLITAN ADMINISTRATION MEDICAL COLLEGE AND VAJIRA HOSPITAL · Aug 22, 2016
Trial Information
Current as of May 03, 2025
Completed
Keywords
ClinConnect Summary
The investigators performed a single center experience accumulated over 12 months since February 2009 with a continuous venovenous hemodiafiltration (CVVHDF) and hybrid technique named sustained low-efficiency dialysis (SLED). The primary end point was death from any cause by day 30. Intensive care unit (ICU) patients were eligible for inclusion when serum creatinine was \> 2 mg/dL, and renal replacement therapy (RRT) was initiated. The selected patients were treated with CVVHDF or SLED.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - The inclusion criteria were
- • 1. AKI requiring RRT
- • 2. Hemodynamic instability defined by systolic blood pressure ≤ 90 mmHg and/or diastolic blood pressure ≤ 60 mmHg
- • 3. Patients requiring initiation to vasopressor support
- Exclusion Criteria:
- • Patients with pre-existing chronic kidney disease ( eGFR less than 30 mLmin/1.73m2) were excluded
About Bangkok Metropolitan Administration Medical College And Vajira Hospital
The Bangkok Metropolitan Administration Medical College and Vajira Hospital is a leading healthcare institution in Thailand, dedicated to advancing medical education, research, and patient care. With a commitment to excellence, the institution supports a wide range of clinical trials aimed at enhancing medical knowledge and improving health outcomes. By fostering collaboration among healthcare professionals, researchers, and patients, it plays a pivotal role in the development of innovative therapies and interventions, contributing significantly to the global healthcare landscape. The institution emphasizes ethical practices and rigorous scientific standards in all its clinical research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bangkok, , Thailand
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials